XML 26 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Cash and Available for Sale Securities
12 Months Ended
Dec. 31, 2012
Cash and Available for Sale Securities [Abstract]  
Cash and Available for Sale Securities
2.           Cash and Available for Sale Securities
 
The following table summarizes the Company's cash and available-for-sale securities' amortized cost and estimated fair value by significant investment category as of December 31, 2012 and 2011 (in thousands):
 
   
Amortized Cost and Estimated Fair Value
 
   
December 31,
 
   
2012
  
2011
 
Cash and cash equivalents:
      
Cash
 $1,203  $7,205 
Cash equivalents
        
Money market mutual funds
  249   1,045 
Certificates of deposit
  500   3,100 
Commercial paper
  4,400   6,600 
Total cash equivalents
  5,149   10,745 
Total cash and cash equivalents
  6,352   17,950 
Short-term investments:
        
Corporate bonds
  1,258   2,031 
Certificates of deposit
  3,301   3,278 
Commercial paper
  4,947   1,500 
Total short-term investments
  9,506   6,809 
Total cash, and cash equivalents, and short-term investments
 $15,858  $24,759 
 
Realized gains and realized losses were not significant for either of the years ended December 31, 2012 or 2011. As of December 31, 2012 and 2011, there were no significant unrealized losses on investments. The cost of all securities sold is based on the specific identification method.
 
The contractual maturities of cash equivalents and short-term investments at December 31, 2012 and 2011 were less than one year. There were no long-term investments at December 31, 2012 and 2011.
 
The Company typically invests in highly-rated securities, and its policy generally limits the amount of credit exposure to any one issuer. When evaluating the investments for other-than-temporary impairment, the Company reviews such factors as the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer, and the Company's intent to sell, or whether it is more likely than not it will be required to sell, the investment before recovery of the investment's amortized cost basis. During the years ended December 31, 2012 and 2011, the Company did not recognize any impairment charges on outstanding investments. As of December 31, 2012, the Company does not consider any of its investments to be other-than-temporarily impaired.